There is something that I would like to point out after reading James J. Riley III’s March 9 column in LNP | LancasterOnline (“Retired Social Security Administration executive examines the ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

Credit cards have notoriously high interest rates, so carrying a balance can be costly. However, some cards offer a path to paying off debt quicker with an introductory 0% APR period. These cards ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of ...

March 24, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders ... and restricted cash balance at the ...

The majority of the remaining capital investment for the WCP A upgrade and transition is scheduled to be incurred during 2025 and we will continue to balance our investment ... of Industry and ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

The AFR is also available from the ‘Trust Documents’ section of the Company’s website: Focusing on high levels of stable and increasing income together with capital growth, this Fund invests in high ...

March 2025 2024 PRELIMINARY RESULTS Kenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers of titanium minerals ...